Zepzelca
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.zepzelca.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Zepzelca
Discover ZEPZELCA, a prescription medication to treat people with metastatic small cell lung cancer (SCLC) who have received treatment with certain other medicinesExplore more
Popular SearchesZepzelcaSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zepzelca your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Zepzelca launches new products
Zepzelca, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Zepzelca recently announced quarterly report
Check out if Zepzelca is spiking on competitors!
Check if Zepzelca has recently received funding, and reach out quickly before it becomes old news!
Click to see if Zepzelca had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Zepzelca has new funding data
Congratulate Masked Content for being promoted to Masked Content at Zepzelca
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Zepzelca as Masked Content
Find more new buyers
Compare Similar Companies to Zepzelca
Compare insights from companies similar to Zepzelca, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Zepzelca
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Zepzelca is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Zepzelca is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zepzelca.
Zepzelca Tech Stack
A closer look at the technologies used by Zepzelca
See more technologies
Zepzelca News & Media
PharmaMar and Jazz Pharmaceuticals Announce Initiation of Confirmatory Phase 3 Clinical Trial of Zepzelca® (lurbinectedin) for the Treatment of Patients with Relapsed Small Cell Lung Cancer
MADRID and DUBLIN, Dec. 13, 2021 /PRNewswire/ -- PharmaMar (MSE: PHM) and partner Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the initiation of a confirmatory Phase 3 clinical trial, LAGOON, evaluating Zepzelca® (lurbinectedin) for the treatment of patients with relapsed small...Jazz Pharmaceuticals Announces Commercial Availability in Canada of Zepzelca™ (lurbinectedin), the First New Treatment for Stage III or Metastatic Small Cell Lung Cancer in More Than a Decade
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) along with partner PharmaMar (MSE: PHM) have announced the commercial availability of ZepzelcaTM (lurbinectedin) after receiving conditional approval by Health Canada in September 2021. Zepzelca is the first new treatment in Canada for adult patients with Stage III or metastatic small cell lung cancer (SCLC) who have progressed on or after platinum-containing therapy in more than a decade.1
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Zepzelca
Sign Up For FreeTo access detailed company insights
Discover ZEPZELCA, a prescription medication to treat people with metastatic small cell lung cancer (SCLC) who have received treatment with certain other medicines... Read More
